导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 42.83% | 67/1050 |
| 近一周 | -3.06% | 794/1104 |
| 近一月 | -9.81% | 1030/1102 |
| 近一季 | -7.70% | 565/1092 |
| 近半年 | 31.56% | 63/1070 |
| 近一年 | 53.94% | 63/1018 |
| 近两年 | 145.08% | 107/926 |
| 近三年 | 120.10% | 70/834 |
| 成立以来 | 91.36% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.54% 846/1070 |
86.32% 80/1101 |
- - |
- - |
| 2025 | 47.51% 223/1065 |
6.06% 337/1014 |
-0.43% 721/1038 |
39.08% 206/1050 |
0.43% 432/1065 |
| 2024 | -0.08% 583/1011 |
5.69% 96/960 |
-0.41% 334/983 |
4.16% 904/991 |
-8.87% 868/1011 |
| 2023 | -9.61% 315/952 |
3.65% 397/880 |
-5.44% 555/895 |
-10.97% 619/915 |
3.59% 34/952 |
| 2022 | -24.83% 488/867 |
-17.05% 361/773 |
5.85% 467/806 |
-13.32% 485/845 |
-1.23% 499/867 |
| 2021 | 15.14% 192/740 |
-4.38% 318/580 |
13.77% 264/659 |
8.06% 83/704 |
-2.06% 513/740 |
| 2020 | 40.45% 298/554 |
-4.61% 279/419 |
18.93% 304/466 |
6.93% 321/517 |
15.79% 188/554 |
| 2019 | 38.90% 228/410 |
27.72% 507/1146 |
-4.59% 679/1228 |
4.72% 206/390 |
8.84% 202/410 |
| 2018 | -22.80% 112/349 |
- - |
-6.70% 247/990 |
-5.56% 484/1000 |
-13.05% 738/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 北信瑞丰研究精选 VS. 东吴新产业精选股票A(580008) |